Scherner C - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.

Mann T, Gerwat W, Batzer J, Eggers K, Scherner C, Wenck H, Stäb F, Hearing VJ, Röhm KH, Kolbe L. Mann T, et al. Among authors: scherner c. J Invest Dermatol. 2018 Jul;138(7):1601-1608. doi: 10.1016/j.jid.2018.01.019. Epub 2018 Feb 7. J Invest Dermatol. 2018. PMID: 29427586 Free article. Clinical Trial.

Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase.

Mann T, Scherner C, Röhm KH, Kolbe L. Mann T, et al. Among authors: scherner c. Int J Mol Sci. 2018 Feb 28;19(3):690. doi: 10.3390/ijms19030690. Int J Mol Sci. 2018. PMID: 29495618 Free PMC article.

4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.

Kolbe L, Mann T, Gerwat W, Batzer J, Ahlheit S, Scherner C, Wenck H, Stäb F. Kolbe L, et al. Among authors: scherner c. J Eur Acad Dermatol Venereol. 2013 Jan;27 Suppl 1:19-23. doi: 10.1111/jdv.12051. J Eur Acad Dermatol Venereol. 2013. PMID: 23205541 Clinical Trial.

Effects of glyceryl glucoside on AQP3 expression, barrier function and hydration of human skin.

Schrader A, Siefken W, Kueper T, Breitenbach U, Gatermann C, Sperling G, Biernoth T, Scherner C, Stäb F, Wenck H, Wittern KP, Blatt T. Schrader A, et al. Among authors: scherner c. Skin Pharmacol Physiol. 2012;25(4):192-9. doi: 10.1159/000338190. Epub 2012 May 15. Skin Pharmacol Physiol. 2012. PMID: 22584263 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters